Table 6.

Prevalence ratio (PR) of willingness to participate in HIV cure research procedures based on gender, employment status, education and the belief that an HIV cure is available

	Gender (TGW/ W vs travestis)			Employment status (employed vs unemployed)			Education (at least high school vs until incomplete high school)			Believe that HIV cure is available (Yes vs No)
	PR	95% CI	P value	PR	95% CI	P value	PR	95% CI	P value	PR	95% CI	P value
New, untested treatments	1.17	0.91 to 1.49	0.12	0.75	0.55 to 1.03	0.01	1.05	0.88 to 1.26	0.57	1.07	0.91 to 1.27	0.45
Early safety studies	1.24	1.00 to 1.52	0.01	0.94	0.78 to 1.12	0.39	1.03	0.89 to 1.19	0.72	1.04	0.89 to 1.19	0.66
Focus group discussions	1.03	0.90 to 1.18	0.62	1.12	1.00 to 1.25	0.09	1.16	1.00 to 1.34	0.02	0.89	0.74 to 1.05	0.09
Tissue biopsies	0.82	0.70 to 0.96	0.05	0.97	0.77 to 1.22	0.79	1.03	0.84 to 1.26	0.76	0.89	0.71 to 1.12	0.25
Therapeutic vaccines	0.99	0.84 to 1.16	0.89	0.86	0.72 to 1.03	0.06	0.99	0.86 to 1.15	0.93	1.01	0.85 to 1.20	0.93
Autologous transplants	0.92	0.83 to 1.03	0.30	0.98	0.84 to 1.14	0.79	0.92	0.82 to 1.03	0.28	0.98	0.83 to 1.16	0.80
Efficacy studies	1.08	0.88 to 1.32	0.42	0.91	0.72 to 1.14	0.32	1.03	0.87 to 1.23	0.69	0.88	0.72 to 1.07	0.16
Blood draws	0.95	0.89 to 1.02	0.26	0.98	0.88 to 1.08	0.59	0.95	0.89 to 1.02	0.27	0.97	0.88 to 1.08	0.63
Online surveys	1.04	0.88 to 1.22	0.61	1.00	0.85 to 1.18	0.98	1.12	0.94 to 1.34	0.15	0.98	0.84 to 1.15	0.80
Leukapheresis/apheresis	1.00	0.81 to 1.25	0.97	1.04	0.86 to 1.26	0.69	1.08	0.88 to 1.32	0.45	0.87	0.70 to 1.08	0.18
Unique proteins or T cells	1.05	0.79 to 1.41	0.69	0.92	0.68 to 1.26	0.59	0.88	0.69 to 1.11	0.31	0.99	0.76 to 1.30	0.96
Broadly neutralising antibodies	1.14	0.83 to 1.55	0.38	0.86	0.63 to 1.18	0.29	0.92	0.71 to 1.21	0.57	1.00	0.74 to 1.36	0.98
Treatment interruption	0.85	0.62 to 1.17	0.37	0.72	0.44 to 1.20	0.13	1.02	0.71 to 1.45	0.92	0.78	0.52 to 1.15	0.17
Phone/in-person interview	1.05	0.86 to 1.27	0.63	1.09	0.92 to 1.30	0.35	1.14	0.94 to 1.39	0.15	0.86	0.68 to 1.09	0.16
Gene editing	0.85	0.62 to 1.17	0.36	0.79	0.53 to 1.18	0.20	0.87	0.63 to 1.21	0.42	0.92	0.65 to 1.29	0.61
Allogenic transplants	0.83	0.64 to 1.08	0.24	0.94	0.68 to 1.31	0.71	0.94	0.69 to 1.27	0.68	0.88	0.63 to 1.22	0.41
Latency reversing agents	1.20	0.77 to 1.87	0.38	1.00	0.67 to 1.49	1.00	1.25	0.85 to 1.84	0.25	0.97	0.63 to 1.49	0.89

Bolded values represent statistically significant findings (p < 0.05).